Endo Int'l (ENDP) to Acquire Auxilium (AUXL) in $2.6B Deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Cantor Fitzgerald Upgrades Endo Health (ENDP) to Hold
October 13, 2014 7:36 AM EDTCantor Fitzgerald upgraded Endo Health (NASDAQ: ENDP) from Sell to Hold.
Analyst Irina Rivkind Koffler said, "Though we take a conservative view of Auxilium's portfolio, we believe that Endo can attain +6.7% EPS accretion in 2015, with longer-term increases in EBITDA to facilitate... More
MKM Partners Downgrades Auxilium Pharmaceuticals (AUXL) to Neutral
October 10, 2014 7:04 AM EDTMKM Partners downgraded Auxilium Pharmaceuticals (NASDAQ: AUXL) from Buy to Neutral.
For an analyst ratings summary and ratings history on Auxilium Pharmaceuticals click here. For more ratings news on Auxilium Pharmaceuticals click here.
Shares of Auxilium Pharmaceuticals closed at $32.44 yesterday.
... MorePiper Jaffray Upgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Overweight
October 10, 2014 6:48 AM EDTPiper Jaffray upgraded Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) from Neutral to Overweight with a price target of $84.00 (from $70.00) following the deal to acquire Auxilium (NASDAQ: AUXL).
Analyst David Amsellem commented, "We believe that the addition of AUXL... More
Mizuho Securities Downgrades Auxilium Pharmaceuticals (AUXL) to Neutral
October 10, 2014 6:35 AM EDTMizuho Securities downgraded Auxilium Pharmaceuticals (NASDAQ: AUXL) from Buy to Neutral.
For an analyst ratings summary and ratings history on Auxilium Pharmaceuticals click here. For more ratings news on Auxilium Pharmaceuticals click here.
Shares of Auxilium Pharmaceuticals closed at $32.44 yesterday.
... MoreQLT, Inc. (QLTI) Reports Termination of Proposed Auxillium (AUXL) Merger
October 9, 2014 6:48 AM EDTQLT, Inc. (NASDAQ: QLTI) has been advised by Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) that Auxilium's board of directors has reviewed an offer from Endo International plc (Nasdaq: ENDP) to acquire all of the... More
QLT, Inc. (QLTI) on Watch Following Endo, Auxillium Deal
October 9, 2014 6:38 AM EDTQLT, Inc. (Nasdaq: QLTI) on watch following news that End International (Nasdaq: ENDP) is moving to acquire Auxilium Pharmaceuticals (Nasdaq: AUXL) for about $2.6 billion.
... More